Summit Therapeutics SMMT
NASDAQ SMMT
$16.75 +0.06 (+0.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Summit Therapeutics (SMMT) posted Depreciation & Amortization (CF) of $46,000 for Q2 2026, up 24.3% from $37,000 a year earlier and up 4.5% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Summit Therapeutics was $174,000, up 67.3% year-over-year; for FY2025, it was $146,000, up 64.0% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
  • In prior years, Summit Therapeutics' Depreciation & Amortization (CF) was $89,000 in FY2024 (-55.1%), $198,000 in FY2023 (-43.3%), $349,000 in FY2022 (+5.8%) and $330,000 in FY2021 (+9.3%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $20,000 in Q2 2024 to a high of $99,000 in Q2 2022 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last five quarters, with growth averaging 39.3% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2021, with growth of 125.7%; the weakest was Q1 2024, with a decline of 70.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $44,000 (Q1 2026), $42,000 (Q4 2025) and $42,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Summit Therapeutics 13.28 Bn 11.04 Bn - 46,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,000.00
Mar 31, 2026 44,000.00
Dec 31, 2025 42,000.00
Sep 30, 2025 42,000.00
Jun 30, 2025 37,000.00
Mar 31, 2025 25,000.00
Dec 31, 2024 22,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 20,000.00
Mar 31, 2024 27,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 32,000.00
Jun 30, 2023 46,000.00
Mar 31, 2023 90,000.00
Dec 31, 2022 88,000.00
Sep 30, 2022 93,000.00
Jun 30, 2022 99,000.00
Mar 31, 2022 69,000.00
Dec 31, 2021 79,000.00
Sep 30, 2021 81,000.00
API Access

Summit Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SMMT&period=max&api_key=YOUR_API_KEY